Locations:
How to care for patients with this rare, complex disease
Tumor factors are more significant, says new study
Study includes largest cohort to date
Multigene panel testing valuable regardless of age, cancer history
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Increased invasive disease-free survival, disease-free survival and overall survival
Prescreening for clots also effective
Should lead to better treatment
High-risk and real-world patients responded
Study explores atezolizumab for myelodysplastic syndrome
FDA approval may come in 2019
Advertisement
Advertisement
Search